All News

Tisagenlecleucel (Kymriah, Novartis) is now approved for the treatment of diffuse large B-cell (DLBCL) lymphoma, as well as high grade B-cell lymphoma and DLBCL arising from follicular lymphoma.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

Trametinib plus dabrafenib is the first oral targeted adjuvant combination therapy to demonstrate significant clinical benefit in patients with a BRAF V600 mutation, following complete surgical resection.

The study found a calculable personal genetic risk score that was applicable to approximately 60,000 patients.

Although current guidelines recommend that HIV primary care intervals do not exceed 6 months, gaps in care up to 9 months do not worsen viral load for patients.

Upgrades to the insulin pen to improve disease management and prevent hypoglycemia due to overdoses are on the horizon.

Procter & Gamble (P&G) announced last month that it has agreed to acquire Merck KGaA’s consumer health unit for 3.4 billion euros or about $4.2 billion.

Top news of the day from across the health care landscape

Top news of the day from across the health care landscape.

BLU-667 is being investigated for the treatment of cancers caused by an alteration in the receptor tyrosine kinase.

Half of all HAE drug expenses were billed through the pharmacy benefit and half through the medical benefit.

HIV targets and disables a pathway involved in blocking viral activity and clearing infection.

Make sure that all individuals involved are exposed to the same process and treated equally, even though the infractions may differ.

The recent Escherichia coli (E.coli) outbreak linked to romaine lettuce is extremely virulent and has affected 22 states across the United States.

Poor study design and reporting in animal research compromises the ethical review of proposed human drug trials.

In an additional analysis from the CANVAS program, new data reinforce evidence of improved renal outcomes for those with type 2 diabetes and chronic kidney disease.

A synthetic bridged nucleic acid was found to greatly improve the accuracy of gene-editing technology, which could potentially lead to new therapies for genetic diseases.

Here is the lowdown on this nutrition plan, which is all the rage.

In this last installment of the series, our expert pharmacists weigh in on a variety of issues

People living with HIV are at elevated risk for hyponatremia, the most common electrolyte disorder seen in hospitals.

As the big day approaches, students may be experiencing many emotions. Here is how to get through the ceremony.

Those who have been putting off making vacation plans or taking personal days should think again.

Pharmacists in all practice settings have opportunities to assist patients who use or seek to use contraception.

The new method indexes thousands of cells simultaneously and could potentially improve understanding of various diseases at a molecular level.

Risankizumab shows promise as an important treatment option for people living with plaque psoriasis.

The findings suggest that a patient’s diet may impact their ability to combat head and neck cancer.

Pharmacists can help identify pharmaceuticals that could trigger symptoms in those with the autoimmune condition.

Medication is not cheap, but we can help ensure that cost is not a barrier to adherence. Here are some tips.